Joint reasoned statement of the Management Board and the Supervisory Board of APONTIS PHARMA AG on the voluntary public purchase offer of Zentiva AG Read more
DE EN
Contents on this page
background
Contact form

Please chose your topic first

Please enter your name and surname.

Please add a subject.

Something is wrong with the email, please check.

Please add a message.

Please approve.

Our contact data at a glance
If you have questions about our products, including medical enquiries, or wish to report adverse drug reactions and quality defects, our team is gladly at your service. You can reach us at the following contact address or, if you prefer, please use the contact form above.
Main Office
  • Main Office
  • Orders for clinics
  • Press enquiries

eMail: info@apontis-pharma.de 

Phone: +49 2173 48 4949

Fax: +49 2173 48 4941

eMail: bestellung-apontis-pharma@pmb2b.de  

Fax: 01803-001371 

eMail: presse@apontis-pharma.de 

Phone: +49 2173 48 1377

Fax: +49 2173 48 4941

Contacts
Engelbertz Pauly Mach-Marschewski